Locations:
Search
Modification of traditional staging factors associated with survival in high-risk disease
Cleveland Clinic’s radiation oncologists select highlights
Hyperthermia, neoadjuvant chemoradiation and reconstruction hold promise of long-term survival
Dose and neutrophil-to-lymphocyte ratio are key factors
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Novel assay identifies women most likely to benefit
Study presented at ASTRO 2021 shows promise in patients treated with stereotactic radiosurgery
Recruitment open for Phase III trial of immunotherapy plus chemotherapy and radiotherapy
Radiation planning technique safely reduces toxicity
Truly personalized radiotherapy may be within reach
Minimizing patient discomfort, improving quality of life
Advertisement
Advertisement